Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination

MRSA Clinical Trial

Official title:

Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03601741
• Other study ID #: 17-01633
• Status: Completed
• Phase: N/A
• Start date: June 8, 2018
• Est. completion date: April 5, 2019

Study information

• Verified date: September 2019
• Source: NYU Langone Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a prospective pilot study using a randomized, controlled, single blinded, crossover trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable wipes which are effective against MRSA. Each participant will then be randomly assigned to 7 days in either the intervention or the control arm. At the end of the 7 days participants stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that they are not in during the first 7 days.

The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days, focusing on the difference between the intervention and the control periods. The secondary endpoint is the rate of hospital acquired MRSA infection in patients treated by residents during each period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1
• Est. completion date: April 5, 2019
• Est. primary completion date: April 5, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Internal Medicine Residents

Exclusion Criteria:

• NA

Related Conditions & MeSH terms

• MRSA

Intervention

Other:
• Daily Antimicrobial Stethoscope Diaphragm Cover
Patients will receive package with instructions to use stethoscope cover, and are then instructed to switch in 7 days
• Uncovered Stethoscopes
Patients receive instruction to begin with no covers, and are then instructed to switch in 7 days

Locations

Country	Name	City	State
United States	New York University School of Medicine	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	MRSA colony count cultured from stethoscope diaphragms	Total CFU of each selected pathogen at 7 days compared by paired Mann-Whitney U tests, with each patient serving as their own control	7 Days
Secondary	Rate of hospital acquired MRSA infection in patients treated by participating residents	Rates on nosocomial infection in each arm compared through use of Kaplan Meier curves	14 Days